Nykode Therapeutics AS (OSL:NYKD)
Norway
· Delayed Price · Currency is NOK 2.406
-0.134 (-5.28%)
Apr 16, 2025, 1:05 PM CET
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of 785.67 million as of April 17, 2025. Its market cap has decreased by -82.94% in one year.
Market Cap
785.67M
Enterprise Value
-486.29M
Revenue
104.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.41
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 5.52B to 785.67M, a decrease of -85.78%. That is a compound annual growth rate of -31.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2025 | 785.67M | -21.01% |
| Dec 30, 2024 | 994.66M | -85.77% |
| Dec 29, 2023 | 6.99B | -15.67% |
| Dec 30, 2022 | 8.29B | -64.54% |
| Dec 30, 2021 | 23.37B | 9.44% |
| Dec 30, 2020 | 21.36B | 286.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 2.96B |
| Nordhealth AS | 2.83B |
| Photocure ASA | 1.44B |
| Vistin Pharma ASA | 1.06B |
| ArcticZymes Technologies ASA | 868.21M |
| Hofseth BioCare ASA | 846.83M |
| Omda AS | 818.26M |
| Thor Medical ASA | 770.30M |